A Randomized Multi-centre Double-blind Placebo Controlled Trial to Demonstrate the Efficacy and Safety of Nabiximols in the Treatment of Adults With Chronic Tic Disorders

Trial Profile

A Randomized Multi-centre Double-blind Placebo Controlled Trial to Demonstrate the Efficacy and Safety of Nabiximols in the Treatment of Adults With Chronic Tic Disorders

Not yet recruiting
Phase of Trial: Phase III

Latest Information Update: 28 Aug 2017

At a glance

  • Drugs Nabiximols (Primary)
  • Indications Gilles de la Tourette's syndrome; Tic disorders
  • Focus Therapeutic Use
  • Acronyms CANNA-TICS
  • Most Recent Events

    • 17 Aug 2017 Planned initiation date changed from 1 Apr 2017 to 1 Dec 2017.
    • 24 Mar 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top